Acute coronary syndromes: Unstable angina and non-Q-wave myocardial infarction

Circulation

Volumn 97, Issue 12, 1998, Pages 1195-1206

  Théroux, Pierre ^b   Fuster, Valentin ^a  

^a MOUNT SINAI MEDICAL CENTER   (United States)

^b MONTREAL HEART INSTITUTE   (Canada)

Author keywords

Heparin; Myocardial infarction; Platelet aggregation inhibitors; Platelets; Thrombosis

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOCHEMICAL MARKER; C REACTIVE PROTEIN; CALCIUM ANTAGONIST; CLOPIDOGREL; CREATINE KINASE; EFTIFIBATIDE; ENOXAPARIN; FIBRINOGEN RECEPTOR ANTAGONIST; GLYCERYL TRINITRATE; HEPARIN; HIRUDIN; LAMIFIBAN; MORPHINE; THROMBIN INHIBITOR; TICLOPIDINE; TIROFIBAN; TROPONIN I; TROPONIN T; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR; WARFARIN;

CLINICAL FEATURE; COMORBIDITY; CREATINE KINASE BLOOD LEVEL; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE MARKER; DISEASE SEVERITY; DRUG INDICATION; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; INTRAVENOUS DRUG ADMINISTRATION; ISCHEMIC HEART DISEASE; MEDICAL CARE; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK ASSESSMENT; THORAX PAIN; UNSTABLE ANGINA PECTORIS;

EID: 19244386852     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.97.12.1195     Document Type: Review

References (60)

1. Braunwald E, Jones RH, Mark DB, Brown J, Brown L, Cheitlin MD, Coneannon CA, Cowan M, Edwards C, Fuster V, Goldman L, Green LA, Grines CL, Lytle BW, McCauley KM, Mushlin AI, Rose GC, Smith EE III, Swam JA, Topol EJ, Willerson JT. Diagnosing and managing unstable angina. Circulation. 1994;90:613-622.
2. Aguirre FV, Younis LL, Chaitman BR, Ross AM, McMahon RP, Kern MJ, Berger PB, Sopke G, Rogers WJ, Shaw L. Early and 1-year clinical outcome of patients evolving non-Q-wave versus Q-wave myocardial infarction after thrombolysis: results from the TIMI II study. Circulation. 1995;91:2541-2548.
3. Zareba W, Moss AJ, Raubertas RF. Risk of subsequent cardiac events in stable convalescing patients after first non-Q-uave and Q-wave myocardial infarction. Coron Artery Dis. 1994;5:1009-1018.
4. Cairns J, Theroux P, Armstrong P, Bogaty P, Kells C, Thompson C, Warnica W. Unstable angina: report from a Canadian expert roundtable. Can J Cardiol. 1996;12:1279-1292.
5. Hamm CW, Goldman GU, Heeschen C, Kreymann G, Berger J, Meinertz T. Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I. N Engl J Med. 1997; 337:1648-1653.
6. Lüscher MS, Thygesen K, Ravkilde J, Heickendorff L, for the TRIM Study Group. Applicability of cardiac troponin T and I for early risk stratification in unstable coronary artery disease. Circulation. 1997;96: 2578-2585.
7. Crea F, Biasucci LM, Buffon A, Liuzzo G, Monaco C, Caligiuri G, Kol A, Sperti G, Cianflone D, Maseri A. Role of inflammation in the pathogenesis of unstable coronary artery disease. Am J Cardiol. 1997;80: 10E-16E.
8. Bosch X, Theroux P, Waters DD, Pelletier GB, Roy D. Early post infarction angina: clinical, angiographic and prognostic significance. Circulation. 1987;75:988-995.
9. Maseri A, L'Abbate A, Baroldi G, Chierchia S, Marzilli M, Ballestra AM, Severi S, Parodi O, Biagini A, Distante A, Pesola A. Coronary vasospasm as a possible cause of myocardial infarction: a conclusion derived from the study of 'preinfarction' angina. N Engl J Med. 1978;299:1271-1277.
10. Rizik DG, Healy S, Margulis A, Vandam D, Bakalyar D, Timmis G, Grines C, O'Neil WW, Schreiber TL. A new classification for hospital prognosis of unstable angina pectoris. Am J Cardiol. 1995;75:993-997.
11. Braunwald E. Unstable angina: a classification. Circulation. 1989;80: 410-414.
12. Ahmed W, Bittl JA, Braynwald E. Relation between clinical presentation and angiographic morphology in unstable angina pectoris. Am J Cordiol. 1988;62:1024-1027.
13. Calvin JE, Klein LW, VandenBerg BJ, Meyer P, Condon JV, Snell RJ, Ramirez-Morgan LM, Parrillo JE. Risk stratification in unstable angina: prospective validation of the Braunwald classification. JAMA. 1995;273: 136-141.
14. Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation. 1995;92:657-671.
15. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med. 1992;326:242-250, 310-318.
16. Burke AP, Farb A, Malcolm GT, Liang YH, Smialek J, Virmani R. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med. 1997;336:1276-1281.
17. Shah PK, Falk E, Badimon JJ, Fernandez-Ortiz A, Mailhac A, Villareal-Levy G, Fallon JT, Regnstrom J, Fuster V. Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques: potential role of matrix-degrading metalioproteintases and implications for plaque rupture. Circulation. 1995;92: 1565-1569.
18. Puster V, Lewis A. Conner Memorial Lecture: Mechanisms leading to myocardial infarction: insights from studies of vascular biology. Circulation. 1994;90:2126-2146.
19. Moreno PR, Bernardi VH, Lopez-Cuellar J, Murcia AM, Palacios IF, Gold HK, Mehran R, Sharma SK, Nemerson Y, Fuster V, Fallon JT. Macrophages, smooth muscle cells and tissue factor in unstable angina: implications for cell mediated thrombogenicity in acute coronary syndromes. Circulation. 1996;94:3090-3097.
20. Libby P. Molecular basis of the acute coronary syndromes. Circulation. 1995;91:2844-2850.
21. Toschi V, Gallo R, Lettino M, Fallon JT, Fernandez-Ortiz A, Badimon L, Chesebro JH, Nemerson Y, Fuster V, Badimon JJ. Tissue factor predicts the thrombogenicity of human atherosclerotic plaque components. Circulation. 1997;95:594-599.
22. Bogaty P, Hackett D, Davies G, Maseri A. Vasoreactivity of the culprit lesion in unstable angina. Circulation. 1994;90:5-11.
23. Willerson JT, Golino P, Eidt J, Campbell WB, Buja M. Specific platelet mediators and unstable coronary artery lesions: experimental evidence and potential clinical implications. Circulations. 1989;80:198-205.
24. Cohen L, Kitzes R. Prompt termination and/or prevention of cold-pressor-stimulus-induced vasoconstriction of different vascular beds by magnesium sulfate in patients, with Prinzmetal's angina. Magnesium. 1986;5: 144-149.
25. Mehta D, Curwin J, Gomes A, Fuster V. Sudden death in coronary artery disease: acute ischemia versus myocardial substrate. Circulation. 1997; 96:3215-3223.
26. Holland Interuniversity Nifedipine/Metoprolol Trial (HINT) Research Group. Early treatment of unstable angina in the coronary care unit: a randomized, double blind, placebo controlled comparison of recurrent ischemia in patients treated with nifedipine or metoprotol or both: Report of the Holland Interuniversity Nifedipine/Metoprolol Trial (HINT) Research Group. Br Heart J. 1986;56:400-413.
27. Gottlieb SO, Weisfeldt ML, Ouyang P, Achuff SC, Baughman KL, Traill TA, Brinker JA, Shapiro EP, Chandra NC, Mellits ED, Townsend SN, Gerstenblith G. Effect of the addition of propranolol to therapy with nifedipine for unstable angina pectoris: a randomized, double-blind, placebo-controlled trial. Circulation. 1986;73:331-337.
28. TIMI IIIB Investigators. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction: results of the TIMI IIIB trial. Circulation. 1994;89:1545-1556.
29. Theroux P, Ouimet H, McCans J, Latour J, Joly P, Lévy G, Pelletier E, Juneau M, Staziak J, DeGuise P, Pelletier GB, Rinzler D, Waters DD. Aspirin, heparin, or both to treat acute unstable angina. N Engl J Med. 1988;319:1105-1111.
30. The RISC Group. Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary disease. Lancet. 1990;336:827-830.
31. Lewis HD, Davis JW, Archibald DG, Steinke WE, Smitherman TC, Doherty JE, Schnaper HW, LeWinter MM, Linares E, Poyget JM, Sabharwai SC, Chester E, DeMots H. Protective effects of aspirin against myocardial infarction and death in men with unstable angina. N Engl J Med. 1983;309:396-403.
32. Cairns JA, Gent M, Singer J, Finnie KJ, Frogatt GM, Holder DA, Jablonsky G, Kostuk WJ, Melendez LJ, Myers MG, Sackett DL, Sealy BJ, Tanser PH. Aspirin, sulfinpyrazone, or both in unstable angina. N Engl J Med. 1985;313:1369-1375.
33. Balsano F, Rizzon P, Violi F, Scrutinio D, Cimmimello C, Aguglia F, Pasotti C, Rudelli G, and the Studio della Ticlopidina nell'Angina Instabile Group. Antiplatelet treatment with ticlopidine in unstable angina: a controlled multicenter clinical trial. Circulation. 1990;82: 17-26.
34. CAPRIE Steering Committee. A randomized, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet. 1996;348:1329-1339.
35. Coller BS. Blockade of platelet GP IIb/IIIa receptors as an antithrombotic strategy. Circulation. 1995;92:2373-2380.
36. The CAPTURE Investigators. Randomized placebo-controlled trial of abciximah before and during coronary intervention in refractory unstable angina: the CAPTURE trial. Lancet. 1997;349:1429-1435.
37. Theroux P, for the PRISM-PLUS Investigators. Platelet receptor inhibition for ischemic syndrome management in patients limited by unstable signs and symptoms. Presented at the American College of Cardiology Scientific Sessions. Anaheim, Calif, March 17, 1997.
38. White HD, on behalf of the Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Study. Presented at the American College of Cardiology Scientific Sessions, Anaheim, Calif, March 17, 1997.
39. Califf R, for the PURSUIT Investigators. Platelet IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin™(PURSUIT). Presented at the European Meeting of Cardiology. Stockholm, August 25, 1997.
40. Cohen M, Adams PC, Parry G, Xiong J, Chamberlain D, Wieczorek I, Fox KAA, Chesebro D, Strain J, Keller C, Kelly A, Lancaster G, Ali J, Kronmal R, Fuster V, and the Antithrombotic Therapy in Acute Coronary Syndromes Research Group. Combination antithrombotic therapy in unstable rest angina and non-Q-wave infarction in norprior aspirin users. Circulation. 1994;89:81-88.
41. Oler S, Whooley MA, Oler J, Grady D. Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina. JAMA. 1996;276:811-815.
42. The FRISC Study Group. Low-molecular-weight heparin during instability in coronary artery disease. Lancet. 1996;347:561-568.
43. Klein W, Buchwald A, Hillis SE, Monrad S, Sanz G, Turpie GG, van der Meer J, Olaisson E, Undeland S, Ludwig K, for the FRIC Investigators. Comparison of low molecular-weight heparin with unfractionated heparin acutely and wih placebo for 6 weeks in the management of unstable coronary artery disease. Circulation. 1997;96:61-68.
44. Cohen M, Demers C, Gurfinkel EP, Turpie AGG, Fromell GJ, Goodman S, Langer A, Califf RM, Fox KAA, Premmereur J, Bigonzi F, for the Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group. Low molecular weight heparin versus unfractionated heparin for unstable angina and non-Q wave myocardial infarction. N Engl J Med. 1997;337:447-452.
45. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIa Investigators Randomized trial of intravenous heparin versus recombinant hirudin for acute coronary syndromes. Circulation 1994;90:1631-1637.
46. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIb Investigators. A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes. N Engl Med. 1996;335:775-782.
47. Organization to Assess Strategies for Ischemic Syndromes (OASIS) Investigators. Comparison of the effects of two doses of recombinant hirudin compared with heparin in patients with acute myocardial ischemia without ST elevation: a pilot study. Circulation. 1997;97:769-777.
48. Théroux P, Waters D, Lam J, Juneau M, McCans J. Reactivation of unstable angina following discontinuation of heparin. N Engl J Med. 1992:327:141-145.
49. Hultgren HN, Pfeifer JF, Angel WW, Lipton MJ, Bilisoly J. Unstable angina: comparison of medical and surgical patients. Am J Cardiol. 1977;39:734-740.
50. Luchi RJ, Scott SM, Deupree RH. Principal Investigators and their Associates of Veterans Administration Cooperative Study No. 28. Comparison of medical and surgical treatment for unstable angina pectoris. N Engl J Med. 1987;316:977-984.
51. The Veteran Affairs Non-Q-wave Infarction Strategies in Hospital (VANQWISH) study. Results presented at the European Heart Association meeting. Stockholm, Sweden, August 25, 1997.
52. The BARI Investigators. Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease: the Bypass Angioplasty Revascularization Investigation (BARI). Circulation. 1997;96:1761-1769.
53. Szatmary LJ, Marco J, Fajadet J, Caster C. The combined use of diastolic counterpulsation and coronary dilation in unstable angina due to multivessel disease under unstable hemodynamic conditions. Int J Cardiol. 1988;19:59-66.
54. Toussaint JF, LaMuraglia GM, Southern JF, Fuster V, Kantor HL. Magnetic resonance images lipid, fibrous, calcified, hemorrhagic, and thrombotic components of human atherosclerosis in vivo. Circulation. 1996;94:932-938.
55. Cascells W, Hathorn B, David M, Krabach T, Vaughn WK, McAllister HA, Bearman G, Willerson JT. Thermal detection of cellular infiltrates in living atherosclerotic plaques: possible implications for plaque rapture and thrombosis. Lancet. 1996;347:1447-1451.
56. Ridker PM, Cusham M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997;336:973-979.
57. Muhlestein JB, Hammond EH, Carlsquist JF, Radickc E, Thomson MJ, Karagounis LA, Woods ML, Anderson JL. Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease. J Am Coll Cardiol. 1996;27:1555-1561.
58. Gupta S, Leatham EW, Carrington D, Mendall MA, Kaski JC, Camm AJ. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction. Circulation. 1997;96:404-407.
59. Gurfinkel E, Bozovich G, Daroca A, Beck E, Mautner B, for the ROXIS Study Group. Randomized trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS pilot study. Lancet. 1997;350:404-407.
60. Scholz W, Albus U, Counillon L, Gögelein H. Lang HJ, Linz W, Weichert A, Schölkens BA. Protective effects of HOE642, a selective sodium-hydrogen subtype 1 inhibitor, on cardiac ischemia and reperfusion. Cardiovasc Res. 1995;29:260-265.